Benign neoplasm: Bones of skull and face

CD2_BENIGN_BONE_SKULL_FACE

oral cavity cancer: A primary or metastatic malignant neoplasm involving the oral cavity. The majority are squamous cell carcinomas.

Suggest a new description

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

473681

1. Apply sex-specific rule

None

473681

2. Check conditions

None

473681

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

2 out of 7 registries used, show all original rules.

310

4. Check minimum number of events

None

310

5. Include endpoints

None

310

6. Filter based on genotype QC (FinnGen only)

301

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2415 1490 909
Only index persons 2235 1407 828
Unadjusted period prevalence (%)
Whole population 0.04 0.04 0.03
Only index persons 0.04 0.05 0.03
Median age at first event (years)
Whole population 44.74 46.07 42.50
Only index persons 44.51 45.72 42.46

-FinnGen-

Key figures

All Female Male
Number of individuals 301 224 77
Unadjusted period prevalence (%) 0.08 0.09 0.04
Median age at first event (years) 49.64 48.73 52.29

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

Mortality – FinRegistry

Association

Association between endpoint CD2_BENIGN_BONE_SKULL_FACE and mortality.

Females

Parameter HR [95% CI] p-value
CD2_BENIGN_BONE_SKULL_FACE 1.02 [0.82, 1.26] 0.858
Birth year 1.001 [0.99, 1.01] 0.875

During the follow-up period (1.1.1998 — 31.12.2019), 106 out of 1100 females with CD2_BENIGN_BONE_SKULL_FACE died.

Males

Parameter HR [95% CI] p-value
CD2_BENIGN_BONE_SKULL_FACE 0.96 [0.73, 1.26] 0.769
Birth year 0.99 [0.98, 1.0] 0.056

During the follow-up period (1.1.1998 — 31.12.2019), 79 out of 659 males with CD2_BENIGN_BONE_SKULL_FACE died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_BONE_SKULL_FACE.

N-year risk Females Males
1 0.069% 0.218%
5 0.548% 1.183%
10 1.618% 2.989%
15 3.316% 5.825%
20 6.126% 9.559%

Relationships between endpoints

Index endpoint: CD2_BENIGN_BONE_SKULL_FACE – Benign neoplasm: Bones of skull and face

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data